These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 4372659

  • 1. Inhibition of hepatic drug metabolism by cyclic 3',5'-adenosine monophosphate.
    Weiner M, Buterbaugh GG, Blake DA.
    Res Commun Chem Pathol Pharmacol; 1972 Mar; 3(2):249-63. PubMed ID: 4372659
    [No Abstract] [Full Text] [Related]

  • 2. Studies on the mechanism of inhibition of drug biotransformation by cyclic adenine nucleotides.
    Weiner M, Buterbaugh GG, Blake DA.
    Res Commun Chem Pathol Pharmacol; 1972 Jul; 4(1):37-50. PubMed ID: 4153090
    [No Abstract] [Full Text] [Related]

  • 3. Effect of experimental diabetes on drug metabolism in the rat.
    Ackerman DM, Leibman KC.
    Drug Metab Dispos; 1977 Jul; 5(4):405-10. PubMed ID: 19220
    [Abstract] [Full Text] [Related]

  • 4. Increase of hepatic L-phenylalanine: pyruvate aminotransferase by glucagon in rats. Possible role of adenosine cyclic 3',5'-monophosphate as a mediator.
    Fuller RW, Snoddy HD, Bromer WW.
    Mol Pharmacol; 1972 May; 8(3):345-52. PubMed ID: 4339289
    [No Abstract] [Full Text] [Related]

  • 5. Inhibition of drug metabolism. 3. Inhibition of hexobarbital metabolism in the intact rat and in the isolated perfused liver by 2-diethylaminoethyl 2,2-diphenylvalerate HC1 (SKF 525-A) and its N-deethylated derivatives.
    Stitzel RE, Anders MW, Mannering GJ.
    Mol Pharmacol; 1966 Jul; 2(4):335-40. PubMed ID: 5968073
    [No Abstract] [Full Text] [Related]

  • 6. The role of cyclic AMP in the control of hepatic glucose production by glucagon and insulin.
    Exton JH, Lewis SB, Ho RJ, Park CR.
    Adv Cyclic Nucleotide Res; 1972 Jul; 1():91-101. PubMed ID: 4353191
    [No Abstract] [Full Text] [Related]

  • 7. Comparative effects of adenosine and adenine and guanine nucleotides on drug biotransformation in rats.
    Weiner M.
    Naunyn Schmiedebergs Arch Pharmacol; 1975 Jul; 288(2-3):233-42. PubMed ID: 169483
    [Abstract] [Full Text] [Related]

  • 8. Sex-dependent effects of cyclic AMP on the hepatic mixed function oxidase system.
    Ross WE, Simrell C, Oppelt WW.
    Res Commun Chem Pathol Pharmacol; 1973 Mar; 5(2):319-32. PubMed ID: 4349298
    [No Abstract] [Full Text] [Related]

  • 9. Induction of glomerulopressin production by cyclic AMP.
    Arany E, Uranga J, Bonetto R, del Castillo E.
    Horm Metab Res; 1985 Feb; 17(2):72-7. PubMed ID: 2985485
    [Abstract] [Full Text] [Related]

  • 10. Effect of glucagon, epinephrine, cyclic 3',5'-AMP, N6-2'-0-dibutyryl cyclic 3',5'-AMP and insulin upon the phosphate exchange of the isolated perfused fed rat liver.
    De Venanzi F, Peña F, Jimenez VO, De Alvarado H.
    Endocrinology; 1974 Sep; 95(3):741-8. PubMed ID: 4368621
    [No Abstract] [Full Text] [Related]

  • 11. Cyclic nucleotides in diabetes mellitus and obesity.
    Exton JH.
    Adv Cyclic Nucleotide Res; 1980 Sep; 12():319-27. PubMed ID: 6250364
    [No Abstract] [Full Text] [Related]

  • 12. Effect of water and food deprivation on hepatic microsomal metabolism of hexobarbital and aniline.
    Baetjer AM, Rubin RJ.
    J Toxicol Environ Health; 1976 Sep; 2(1):131-8. PubMed ID: 994238
    [Abstract] [Full Text] [Related]

  • 13. Comparative effect of physiological levels of leptin and insulin on cyclic AMP-induced stimulation of hepatic glycogen breakdown.
    Vardanega-Peicher M, Curi R, Souza HM, Borba-Murad GR, Siqueira VL, Galende S, Bazotte RB.
    Pol J Pharmacol; 2003 Sep; 55(4):659-62. PubMed ID: 14581728
    [Abstract] [Full Text] [Related]

  • 14. [Study of hepatic alcohol dehydrogenase inhibition by pyrazole. II. Demonstration of the role of liver ADH in the in vivo metabolism of hydroxyl compounds].
    Reynier M.
    Agressologie; 1970 Sep; 11(5):407-16. PubMed ID: 5516968
    [No Abstract] [Full Text] [Related]

  • 15. ALA synthetase induction. Inhibitory effect exerted by administration of dibutyryl adenosine-3',5'-cyclic monophosphate, theophylline and caffeine.
    Pinelli A, Capuano A.
    Enzyme; 1973 Sep; 16(1):203-10. PubMed ID: 4364572
    [No Abstract] [Full Text] [Related]

  • 16. Effect of glucagon, dibutyryl adenosine 3',5'-cyclic monophosphate and phosphodiesterase inhibitors on rat liver phosphorylase activity and adenosine 3',5'-cyclic monophosphate levels.
    Ingebretsen C, Clark JF, Allen DO, Ashmore J.
    Biochem Pharmacol; 1974 Aug; 23(15):2139-46. PubMed ID: 4369954
    [No Abstract] [Full Text] [Related]

  • 17. Cyclic adenosine 3':5'-monophosphate and the induction of deoxyribonucleic acid synthesis in liver.
    Short J, Tsukada K, Rudert WA, Lieberman I.
    J Biol Chem; 1975 May 25; 250(10):3602-6. PubMed ID: 165178
    [Abstract] [Full Text] [Related]

  • 18. The effect of starvation on the kinetics of drug oxidation by hepatic microsomal enzymes from male and female rats.
    Gram TE, Guarino AM, Schroeder DH, Davis DC, Reagan RL, Gillette JR.
    J Pharmacol Exp Ther; 1970 Oct 25; 175(1):12-21. PubMed ID: 5471443
    [No Abstract] [Full Text] [Related]

  • 19. Stereoselective metabolism of the enantiomers of hexobarbital.
    Furner RL, McCarthy JS, Stitzel RE, Anders MW.
    J Pharmacol Exp Ther; 1969 Oct 25; 169(2):153-8. PubMed ID: 5824599
    [No Abstract] [Full Text] [Related]

  • 20. Effect of exposure to lindane on drug metabolism: decreased hexobarbital sleeping-times and increased antipyrine disappearance rate in rats.
    Kolmodin-Hedman B, Alexanderson B, Sjöqvist F.
    Toxicol Appl Pharmacol; 1971 Nov 25; 20(3):299-307. PubMed ID: 4109017
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.